XLON
BELL
Market cap4mUSD
May 29, Last price
0.75GBP
1D
-11.76%
1Q
-60.53%
IPO
-98.64%
Name
Belluscura PLC
Chart & Performance
P/E
—
P/S
557.71
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.86%
Rev. gr., 5y
27.44%
Revenues
825k
-40.96%
Net income
-19m
L+111.32%
CFO
-9m
L-38.74%
Earnings
Jun 25, 2025
Profile
Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑11 | |
| Income | ||||||||
Revenues | 825 -40.96% | 1,398 232.63% | ||||||
Cost of revenue | 8,622 | 8,132 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (7,797) | (6,734) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | 610 | |||||||
Tax Rate | ||||||||
NOPAT | (7,797) | (7,344) | ||||||
Net income | (18,518) 111.32% | (8,763) 74.19% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 4,236 | 7,419 | ||||||
BB yield | -14.13% | -8.59% | ||||||
| Debt | ||||||||
Debt current | 164 | 130 | ||||||
Long-term debt | 286 | 530 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | (1,691) | (1,385) | ||||||
| Cash flow | ||||||||
Cash from operating activities | (9,132) | (14,906) | ||||||
CAPEX | (85) | (5,077) | ||||||
Cash from investing activities | (4,533) | (5,077) | ||||||
Cash from financing activities | 12,511 | 7,288 | ||||||
FCF | (1,689) | (14,731) | ||||||
| Balance | ||||||||
Cash | 2,141 | 2,045 | ||||||
Long term investments | ||||||||
Excess cash | 2,099 | 1,975 | ||||||
Stockholders' equity | (26,790) | (8,648) | ||||||
Invested Capital | 44,707 | 29,311 | ||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 130,395 | 131,797 | ||||||
Price | 0.23 -64.89% | 0.66 -41.52% | ||||||
Market cap | 29,991 -65.26% | 86,327 -29.80% | ||||||
EV | 28,300 | 89,487 | ||||||
EBITDA | (4,495) | (3,679) | ||||||
EV/EBITDA | ||||||||
Interest | 828 | 24 | ||||||
Interest/NOPBT | ||||||||